Navigation Links
Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer
Date:3/31/2009

SAN DIEGO, March 31 /PRNewswire-FirstCall/ --- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that its Board of Directors has appointed Michael Narachi as President and Chief Executive Officer of the Company, effective immediately. Narachi succeeds Eckard Weber M.D., Executive Chairman and Interim President and CEO.

"Michael brings nearly a quarter century of biotechnology and pharmaceutical experience in clinical development, commercialization, strategic business development and planning to Orexigen," said Eckard Weber, M.D., Executive Chairman and Interim President and CEO of Orexigen. "We are confident that his broad expertise will be instrumental as we focus on FDA approval of Contrave(R), exploring partnership opportunities and executing on broader business strategies."

As President and CEO, Narachi will see through the completion of the remaining three Phase 3 trials for Contrave (naltrexone sustained release (SR)/bupropion SR) and its NDA filing, which is on track for the first half of 2010. Narachi also will oversee the development of Empatic(TM) (zonisamide SR/bupropion SR), which is in the later stages of Phase 2 clinical development.

"I'm thrilled to join the Orexigen team and to have the opportunity to impact the treatment of obesity, a disease of epidemic proportions worldwide with a significant unmet need," said Narachi. "I believe in the Orexigen opportunity and, in particular, in the potential of this approach to help patients who suffer from obesity and its related co-morbidities."

Prior to joining Orexigen, Narachi, age 50, served as Chairman, Chief Executive Officer and President of Ren Pharmaceuticals, Inc., a private biotechnology company and Executive Chairman of the Board of Naryx Pharma,
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Orexigen(R) Therapeutics Names Patrick Mahaffy to Board of Directors
2. Orexigen(R) Therapeutics to Speak at J.P. Morgan Healthcare Conference
3. Orexigen(R) Therapeutics Announces Webcast of Third Quarter Financial Results on November 6, 2008
4. Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City
5. Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
6. Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes
7. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
8. MRSA study suggests strategy shift needed to develop effective therapeutics
9. Cell Therapeutics, Inc. (CTI) President Craig Philips to Present at Invest Northwest
10. MPM Capital Leads Investment in Proteon Therapeutics
11. Cell Therapeutics Reschedules Special Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... National Institute of Arthritis and Musculoskeletal and Skin Diseases ... Ross Prize in Molecular Medicine, conferred by the Feinstein ... award will be given on June 9 at the ... scientific presentations by Dr. O,Shea and other prominent researchers. ... , The award, which includes a $50,000 prize from ...
(Date:4/23/2014)... LAFAYETTE, Ind. - Purdue University researchers have developed a ... living cell by using tiny gold particles with tails ... professor of agricultural and biological engineering, used gold nanoparticles ... known as BRCA1 messenger RNA splice variants, which can ... number of these mRNA splice variants in a cell ...
(Date:4/23/2014)... testosterone falls below normal levels are more likely to ... heart disease and type 2 diabetes. A new simple ... testing and possible treatment is described in an article ... publication from Mary Ann Liebert, Inc., publishers. The article ... Health website at http://www.liebertpub.com/jmh . ...
(Date:4/23/2014)... As evidence mounts showing the potential health benefits of ... people are taking supplements. And the chemical industry is ... supplements, health effects could deter growth, so the industry ... claims, according to the cover story in Chemical ... of the American Chemical Society. , Melody M. Bomgardner, ...
(Date:4/23/2014)... scientists led by a researcher from the Cancer Science ... of Singapore has identified the cancer specific stem cell ... possibility of developing new drugs for the treatment of ... research group, led by Dr Chan Shing Leng, Research ... time that a cancer-specific variant of a cell surface ...
Breaking Medicine News(10 mins):Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Gold nanoparticles help target, quantify breast cancer segments in a living cell 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3
... Pediatric Daytime Sleepiness Scale (PDSS) is an independent, reliable ... breathing disorder and daytime sleepiness on a teenagers academic ... 1 issue of the journal SLEEP. , The study, ... in Buenos Aires, Argentina, focused on 2,884 students, whose ...
... VA As the obesity epidemic grows in ... far reaching health concerns for overweight children. Sleep-disordered ... ranging in severity from snoring to obstructive sleep ... and African- American, according to a new study ...
... California,s,stem cell agency is inviting for-profit companies ... the Foundation for Taxpayer and Consumer Rights,(FTCR) noted ... to scrutinize the awards process to prevent abuse., ... has just,issued calls for applications for two types ...
... Association (USGA) awarded a $20,000 matching grant to Marianjoy,Rehabilitation ... and the creation of a golf program at Marianjoy,for ... USGA has supported programs that bring the game,of golf ... Golf Pro,who leads the Winter Therapeutic Golf Clinics at ...
... Front Needs of Families of Fallen Service Members -, ... to the Nevada National Guard Patriots Fund, which will,support families ... Scott Celley, vice president of external affairs at TriWest, ... p.m. on Tuesday, Dec.,4 on the Flightline of the Nevada ...
... of relationships between parents and their adult children improve ... researcher has found. , Karen Fingerman, an associate professor ... Consumer and Family Sciences, examined relationships adults 70 and ... offspring. The parents in the study also suffered either ...
Cached Medicine News:Health News:PDSS reliable in measuring impact of sleep disorders on teens' academic performance 2Health News:Childhood sleep-disordered breathing disproportionately affects obese and African-Americans 2Health News:Close Scrutiny Needed as First Stem Cell Grants Offered to For-Profit Companies, Consumers Say 2Health News:Marianjoy Rehabilitation Hospital Therapeutic Golf Program Receives a $20,000 Matching Grant From the USGA 2Health News:TriWest Contributes $25,000 to Nevada National Guard 2Health News:Aging improves parent, child relationships, research shows 2
(Date:1/15/2014)... AARP Foundation today announced it has established a ... severe cold weather that has gripped much of the nation. ... need; so to support these emergency relief efforts AARP and ... could mean up to $500,000 in aid. The matching program ...
(Date:1/15/2014)... , January 15, 2014 Shire plc (LSE: SHP, ... Office of Fair Trading (OFT) approval condition to the announced tender ... VPHM).   As a result of the waiver, the ... to complete the tender offer on January 24, 2014 following the ...
(Date:1/15/2014)... 2014  In an unprecedented effort to curb the spread of "superbugs" ... transport vehicles, an advanced and portable UV germicidal lamp manufactured by ... time. In order to prevent EMS paramedics and ... West Palm Beach Fire Rescue is the first ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2
... 2011 Generex Biotechnology Corporation (OTCBB: GNBT) ( ... subsidiary Antigen Express, Inc. ( www.antigenexpress.com ) presented ... with an off-the-shelf immunotherapeutic cancer vaccine, AE37, in ... Sixth Annual ImVacS: The Immunotherapeutics and Vaccine Summit ...
... Inc. (Nasdaq: REGN ) today announced that clinical ... will be presented at the upcoming American Society of Retina ... 22, 2011 in Boston, Massachusetts. The presentations ... Phase 3 VIEW 1 and VIEW 2 Studies Comparing VEGF ...
Cached Medicine Technology:Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 2Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 3Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program 4Regeneron Announces Clinical Presentations at ASRS 2011 Annual Meeting 2Regeneron Announces Clinical Presentations at ASRS 2011 Annual Meeting 3
... The Kisses tag is part of ... the Hugs system. The Kisses tag ... after it has been bonded with ... baby. he two tags remain electronically ...
The PDC Smart® Key Fob can be programmed on demand using a 13.56 MHz RFID reader/writer and is ideal for long-term use applications such as electronic access control or loyalty programs....
... VeriMed can provide healthcare professionals witha ... or shecant speak, cant remember, oris ... to affected individuals. The application can ... obtain a comparable level of care ...
... component of the Hugs system ... staff in matching infants with ... hospital. With the Kisses ... effective and electronic enhancement to ...
Medicine Products: